What guidelines should or should not be: Implications for guideline production

Nephrology Dialysis Transplantation

Volumn 28, Issue 8, 2013, Pages 1980-1984

  Van Biesen, Wim ^a   Van Der Veer, Sabine N ^a,b   Jager, Kitty J ^b   Fouque, Denis ^c   Wanner, Christoph ^d   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Evidence based medicine; Guideline; Nephrology; Shared decision making

Indexed keywords

ARTICLE; AWARENESS; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; MEDICAL DECISION MAKING; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; TREATMENT PLANNING;

EVIDENCE-BASED MEDICINE; GUIDELINE; NEPHROLOGY; SHARED DECISION MAKING;

DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 84884576368     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft291     Document Type: Article

References (36)

1. Zoccali C, Abramowicz D, Cannata-Andia JB et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008; 23: 2162-6. Epub 2008/05/13
2. Nistor I, Van Biesen W. Why consistent and complete outcome reporting is important: the need for a Standardized Outcomes in Nephrology-Guidance (SONG) initiative. Nephrol Dial Transplant. 2013
3. Tangri N, Tighiouart H, Meyer KB et al. Both patient and facility contribute to achieving the Centers for Medicare and Medicaid Services' pay-for-performance target for dialysis adequacy. J Am Soc Nephrol 2011; 22: 2296-302. Epub 2011/10/26
4. Atkins D, Best D, Briss PA et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490. Epub 2004/06/19
5. Fouque D, Laville M, Haugh M et al. Systematic reviews and their roles in promoting evidence-based medicine in renal disease. Nephrol Dial Transplant 1996; 11: 2398-401. Epub 1996/12/01
6. Sackett DL, Rosenberg WM, Gray JA et al. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-2. Epub 1996/01/13
7. Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Seminars in dialysis. 2001; 14: 157-9. Epub 2001/06/26
8. Spiegel B, Bolus R, Desai AA et al. Dialysis practices that distinguish facilities with below-versus above-expected mortality. Clin J Am Soc Nephrol 2010; 5: 2024-33. Epub 2010/09/30
9. Plantinga LC, Fink NE, Jaar BG et al. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res 2007; 7: 5. Epub 2007/01/11
10. Nagler E. ERBP Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant 2013
11. Balshem H, Helfand M, Schunemann HJ et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-6. Epub 2011/01/07
12. Stel VS, Jager KJ, Zoccali C et al. The randomized clinical trial: an unbeatable standard in clinical research? Kidney international. 2007; 72: 539-42. Epub 2007/06/29
13. Jager KJ, Stel VS, Wanner C et al. The valuable contribution of observational studies to nephrology. Kidney Int 2007; 72: 671-5. Epub 2007/06/29
14. Manns B, Owen WF, Jr, Winkelmayer WC et al. Surrogate markers in clinical studies: problems solved or created? Am J Kidney Dis 2006; 48: 159-66. Epub 2006/06/27
15. Ioannidis JP. Why most published research findings are false: author's reply to Goodman and Greenland. PLoS Med 2007; 4: e215. Epub 2007/06/28
16. Rosenbaum SE, Glenton C, Nylund HK et al. User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews. J Clin Epidemiol 2010; 63: 607-19. Epub 2010/05/04
17. Palmer SC, Sciancalepore M, Strippoli GF. Trial quality in nephrology: how are we measuring up? Am J Kidney Dis 2011; 58: 335-7. Epub 2011/08/23
18. Coyne DW. Practice recommendations based on low, very low, and missing evidence. Clin J Am Soc Nephrol 2007; 2: 11-2. Epub 2007/08/21
19. Snowdon C, Elbourne DR, Garcia J et al. Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study. Trials 2006; 7: 34. Epub 2006/12/23
20. van der Veer STC, Jager K, Van Biesen W. Bridging the gap between what we know and what we do in renal medicine: improving the implementability of the European Renal Best Practice guidelines. Nephrol Dial Transplant
21. Llewellyn-Thomas HA, Crump RT. Decision support for patients: values clarification and preference elicitation. Med Care Res Rev 2013; 70: 50S-79S. Epub 2012/11/06
22. Smith QW, Street RL, Jr, Volk RJ et al. Differing levels of clinical evidence: exploring communication challenges in shared decision making. Med Care Res Rev 2013; 70: 3S-13S. Epub 2012/12/12
23. Kahneman D, Slovic P, Tversky A. Judgment under uncertainty: Heuristics and biases. Cambridge: Cambridge University Press, 1982
24. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981; 211: 453-8. Epub 1981/01/30
25. Stanovich KE, West RF. On the relative independence of thinking biases and cognitive ability. J Pers Soc Psychol 2008; 94: 672-95. Epub 2008/03/26
26. Rabin W. Risk aversion and expected utility theory: a calibration theorem. Econometrica 2000; 68: 1281-1292
27. Salpeter SR, Greyber E, Pasternak GA et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010: CD002967. DOI: 10.1002/14651858.CD002967.pub4
28. Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008; 40: 411-7. Epub 2008/03/28
29. Bogdan-Lovis E, Fleck L, Barry HC. It's NOT FAIR! Or is it? The promise and the tyranny of evidence-based performance assessment. Theor Med Bioeth 2012; 33: 293-311. Epub 2012/07/25
30. Uhlig K, Macleod A, Craig J et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 70: 2058-65. Epub 2006/09/28
31. Kiefe CI, Allison JJ, Williams OD et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001; 285: 2871-9. Epub 2001/06/13
32. Howard AD, Howard RS, Goldstein SL et al. Fistula First Breakthrough Initiative (FFBI): lessons about arteriovenous fistula prevalence goals. Am J Kidney Dis 2012; 61: 523-525
33. Vachharajani TJ, Moossavi S, Jordan JR et al. Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clin J Am Soc Nephrol 2011; 6: 1663-7. Epub 2011/06/21
34. Schinstock CA, Albright RC, Williams AWet al. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol 2011; 6: 1996-2002. Epub 2011/07/09
35. Kotter T, Blozik E, Scherer M. Methods for the guideline-based development of quality indicators-a systematic review. Implementation Sci 2012; 7: 21. Epub 2012/03/23
36. Sugarman JR, Frederick PR, Frankenfield DL et al. Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: process, outcomes and implications. Am J Kidney Dis 2003; 42: 806-12. Epub 2003/10/02